SEC Form D · filed March 14, 2014
IRX Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (20)
John T. Spitznagel · New York, NYDirectorFerid D. Murad · New York, NYDirectorJeffrey Hwang · New York, NYExecDavid H. Deming · New York, NYDirectorJohn W. Hadden Ii · New York, NYExec · DirectorJohn D. Halpern · New York, NYDirectorGeorge P. Denny Iii · New York, NYDirectorLawrence M. Wolf · New York, NYDirectorCurtis P. Robb · New York, NYExecZygmund P. Roth · New York, NYExecDale S. Okonow · Lexington, MADirectorEric Strasser · San Francisco, CADirectorMatthew Mckissock · Warren, PADirectorJohn D. Rexford · Las Vegas, NVDirectorLisa M. Garcia · Boston, MAExecCharles H. Brandes · San Diego, CAExecJohn N. Spencer, Jr · Memphis, TNExec · DirectorMcKissock Capital Management, LLC · Warren, PADirectorJohn C. Pernell, Jr · Johns Island, SCExecJohn T. Spitznagel · New York, NYDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗